Haac BE, et al. – The present study was carried out to depict patient preferences towards cost, complication profile, and administration route (oral tablet vs. subcutaneous injection). It was observed in the findings that patients preferred oral prophylaxis and were most concerned about the risk of death from pulmonary embolism (PE). The discoveries estimated the trade–offs acceptable to patients and heterogeneity in preferences for venous thromboembolism (VTE) prophylaxis.